Company: PHAT
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001193125-25-257390
Chunk: 1

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-10-30
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
at September 30, 2025 and December 31, 2024; no shares issued and outstanding at September 30, 2025 and December 31, 2024

     —

     —

     Common stock, $0.0001 par value; authorized shares — 400,000,000 at September 30, 2025 and December 31, 2024; issued and outstanding shares — 71,043,149 and 68,518,238 at September 30, 2025 and December 31, 2024, respectively

     6

     6

     Treasury stock — 19 shares at September 30, 2025 and December 31, 2024

     —

     —

     Additional paid-in capital

     1,040,570

     1,009,425

     Accumulated deficit

     (1,463,110
     )

     (1,263,011
     )

     Total stockholders’ deficit

     (422,534
     )

     (253,580
     )

     Total liabilities and stockholders’ deficit
      
     $
     240,289

     $
     378,318

See accompanying notes.